JPS5951269A - トリフエニルイミダゾリルオキシアルカン酸およびその誘導体 - Google Patents

トリフエニルイミダゾリルオキシアルカン酸およびその誘導体

Info

Publication number
JPS5951269A
JPS5951269A JP58136907A JP13690783A JPS5951269A JP S5951269 A JPS5951269 A JP S5951269A JP 58136907 A JP58136907 A JP 58136907A JP 13690783 A JP13690783 A JP 13690783A JP S5951269 A JPS5951269 A JP S5951269A
Authority
JP
Japan
Prior art keywords
acid
yloxy
esters
acceptable salts
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58136907A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0456030B2 (en, 2012
Inventor
ハンス−ハイネル・ラウテンシユレ−ガ−
アンドレ・ヴエルテル
ゲルト・ヒルボル
ヨハネス・ヴインケルマン
ゲリツト・プロプ
アクセル・ブレクレ
オツトフリ−ド・ツイ−レンベルク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of JPS5951269A publication Critical patent/JPS5951269A/ja
Publication of JPH0456030B2 publication Critical patent/JPH0456030B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP58136907A 1982-07-29 1983-07-28 トリフエニルイミダゾリルオキシアルカン酸およびその誘導体 Granted JPS5951269A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3228271.0 1982-07-29
DE3228271A DE3228271A1 (de) 1982-07-29 1982-07-29 Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
JPS5951269A true JPS5951269A (ja) 1984-03-24
JPH0456030B2 JPH0456030B2 (en, 2012) 1992-09-07

Family

ID=6169571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58136907A Granted JPS5951269A (ja) 1982-07-29 1983-07-28 トリフエニルイミダゾリルオキシアルカン酸およびその誘導体

Country Status (13)

Country Link
US (1) US4460598A (en, 2012)
EP (1) EP0104342B1 (en, 2012)
JP (1) JPS5951269A (en, 2012)
AT (1) ATE25246T1 (en, 2012)
DE (2) DE3228271A1 (en, 2012)
DK (1) DK158723C (en, 2012)
ES (1) ES524512A0 (en, 2012)
FI (1) FI79302C (en, 2012)
GR (1) GR78654B (en, 2012)
IE (1) IE55485B1 (en, 2012)
NO (1) NO160579C (en, 2012)
PT (1) PT77125B (en, 2012)
ZA (1) ZA834648B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208967A (ja) * 1984-03-02 1985-10-21 メルク　エンド　カムパニ−　インコ−ポレ−テツド ピリミジン−４−オンの３−アミノ−２−ヒドロキシプロピル誘導体

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504678A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
DE3504677A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-yloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504680A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Neue ether des 2-hydroxyimidazols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3504679A1 (de) * 1985-02-12 1986-08-14 A. Nattermann & Cie GmbH, 5000 Köln Amide der 2-imidazolyloxyalkansaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPH0680057B2 (ja) * 1986-04-28 1994-10-12 保土谷化学工業株式会社 トリフエニルイミダゾ−ル及びその二量体
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
US4900744A (en) * 1988-09-14 1990-02-13 E. I. Du Pont De Nemours And Company Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US5166214A (en) * 1988-12-05 1992-11-24 Du Pont Merck Pharmaceutical Company Use of imidazoles for the treatment of atherosclerosis
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
US4994482A (en) * 1989-07-31 1991-02-19 Bristol-Myers Squibb Company Arylpyrazol derivatives as anti-platelet agents, compositions and use
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5262540A (en) * 1989-12-20 1993-11-16 Bristol-Myers Squibb Company [2(4,5-diaryl-2 oxazoyl substituted phenoxy alkanoic acid and esters
US5152988A (en) * 1990-02-07 1992-10-06 Merck & Co., Inc. Imidazole compounds in compositions and methods in thrombolytic therapy
US5011851A (en) * 1990-02-13 1991-04-30 Bristol-Myers Squibb Co. Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
GB9019838D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
US5428041A (en) * 1991-05-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
ATE193290T1 (de) * 1992-02-11 2000-06-15 Smithkline Beecham Corp Coa-it- und paf-inhibitoren
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
SE527381C3 (sv) * 2003-04-14 2006-03-21 Linnman Elektronik Ab Gemensam fältbuss för överföring av data och energi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636003A (en) * 1969-11-17 1972-01-18 Geigy Chem Corp Substituted 2-mercaptoimidazole derivatives
DE2934746A1 (de) * 1979-08-28 1981-03-19 A. Nattermann & Cie GmbH, 5000 Köln Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2950478A1 (de) * 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3042466A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208967A (ja) * 1984-03-02 1985-10-21 メルク　エンド　カムパニ−　インコ−ポレ−テツド ピリミジン−４−オンの３−アミノ−２−ヒドロキシプロピル誘導体

Also Published As

Publication number Publication date
FI832730A0 (fi) 1983-07-28
NO160579B (no) 1989-01-23
FI832730L (fi) 1984-01-30
PT77125A (en) 1983-08-01
EP0104342A1 (de) 1984-04-04
DK346783D0 (da) 1983-07-28
DK346783A (da) 1984-01-30
IE831483L (en) 1983-12-29
DK158723B (da) 1990-07-09
DK158723C (da) 1990-12-10
FI79302C (fi) 1989-12-11
FI79302B (fi) 1989-08-31
DE3369508D1 (en) 1987-03-05
JPH0456030B2 (en, 2012) 1992-09-07
IE55485B1 (en) 1990-09-26
NO160579C (no) 1989-05-03
GR78654B (en, 2012) 1984-09-27
DE3228271A1 (de) 1984-02-02
ES8404332A1 (es) 1984-04-16
US4460598A (en) 1984-07-17
ES524512A0 (es) 1984-04-16
PT77125B (en) 1986-01-24
EP0104342B1 (de) 1987-01-28
ATE25246T1 (de) 1987-02-15
NO832630L (no) 1984-01-30
ZA834648B (en) 1984-03-28

Similar Documents

Publication Publication Date Title
JPS5951269A (ja) トリフエニルイミダゾリルオキシアルカン酸およびその誘導体
JPS6011028B2 (ja) 新規４−（ポリアルコキシ−フエニル）−２−ピロリドンの製法
JP2007503423A (ja) フェキソフェナジンの結晶多形、及びそれらを製造する方法
IE52079B1 (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alkanoic acids,salts and esters thereof,process for producing the same and pharmaceutical preparations containing the same
FR2522324A1 (fr) Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant
JPS6277375A (ja) Ｎ―置換２―アミノチアゾール類及び治療用組成物
US5153207A (en) Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
EP0008645B1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
CA1253159A (en) 4-hydroxymethyl-pyrrolidinones substituted in the one position, processes for preparing them, pharmaceutical compositions and intermediate products for preparing them, pharmaceutical compositions and intermediate products
CA1339687E (en) Indole derivatives, processes for their preparation, and their use as medicaments
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
EP0475214B1 (en) Caffeic acid derivatives and pharmaceutical compositions containing the same
IL33530A (en) Benzylidene amino-oxyalkyl carboxylic acids and carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE69104719T2 (de) Alkoxy-substituierte dihydrobenzopyran-2-carbonsäure und deren derivate.
US4071686A (en) Novel benzylidene amino-oxyalkyl carboxylic acids and carboxylic acid derivatives
DE69515498T2 (de) Naphthyridinderivate
KR900006682B1 (ko) 디히드로피리딘과 그 반응 중간체의 제조 방법
US4126625A (en) Certain 5-substituted-3-methyl-2-benzofuran acetic acids
US4792570A (en) 3- and 4-biphenyloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents
CH671396A5 (en, 2012)
US4196216A (en) Novel benzylidene amini-oxyalkyl carboxylic acids and carboxylic acid derivatives
US4172145A (en) Benzo(b)furylacetic acid derivatives to reduce inflammation
US3883538A (en) Dioxolanes and oxathiolanes
FR2544313A1 (fr) Les n-cycloalcoyl methyl-2 oxo-3 diaryl 5-6 as triazines, leur procede de fabrication et leur utilisation en tant que medicament
DE3705149A1 (de) 9,10-dihydro-phenanthrenderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten